CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to enhance the development of tuberculosis vaccines by advancing promising candidates to clinical stages, innovating new vaccine strategies, and discovering biomarkers for clinical trials. It focuses on addressing the global challenge of tuberculosis, particularly drug-resistant strains, to reduce dise…
With 14.4 million prevalent cases and 1.7 million deaths tuberculosis (TB) remains one of the most serious infectious diseases to date.
An estimated 2 billion people are believed to be infected with Mycobacterium tuberculosis and at risk of developing disease.
Multi- and extensively drug resistant strains are increasingly appearing in many parts of the world, including Europe.
While with current control measures the Millennium Development Goals (MDGs) set for 2015 may be achieved, reaching these…
STICHTING TUBERCULOSIS VACCINE INITIATIVE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Ulm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Leiden University Medical Center
Netherlands, Leiden
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
